α-Glucosidase inhibitors and their use in clinical practice

Post-prandial hyperglycemia still remains a problem in the management of type 2 diabetes mellitus. Of all available anti-diabetic drugs, α-glucosidase inhibitors seem to be the most effective in reducing post-prandial hyperglycemia. We conducted a review analyzing the clinical efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Derosa, Giuseppe, Maffioli, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Mini-Special Issue paper: Management of diabetic patients with hypoglycemic agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506243/
https://www.ncbi.nlm.nih.gov/pubmed/23185202
http://dx.doi.org/10.5114/aoms.2012.31621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506243/
https://www.ncbi.nlm.nih.gov/pubmed/23185202
http://dx.doi.org/10.5114/aoms.2012.31621

Ejemplares similares